Task: Please answer the multiple choice question.
Question: Rank these molecules from shortest to longest drug half life time in humans after IV administration.
Constraint: You must select all options from a, b, c, d, or e without using any other words.
Options:
a: Nc1ncnc2c1ncn2CCOCP(=O)(O)O
b: C[C@@H](c1ncncc1F)[C@](O)(Cn1cncn1)c1ccc(F)cc1F
c: NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NCNS2(=O)=O
d: CCc1c2c(nc3ccc(OC(=O)N4CCC(N5CCCCC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC
e: CCC1(c2ccccc2)C(=O)NC(=O)NC1=O
Answer: d
Task: Please answer the multiple choice question.
Question: Rank these molecules from shortest to longest {half_life_duration__names__noun}.
Constraint: You must select all options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%half_life_duration%}
Answer: {%multiple_choice_result}
[(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-piperidin-1-ylpiperidine-1-carboxylate